Lemaitre Vascular INC Form 4 insider transactions

Lemaitre Vascular Director John James O'Connor acquired 5 shares of common stock through the vesting of restricted and performance stock units.

Bridget A Ross, a director at Lemaitre Vascular Inc., acquired 5 shares of common stock through the vesting of restricted and performance stock units.

Lemaitre Vascular Director John A. Roush acquired five shares of common stock through the release of dividend equivalent rights tied to restricted and performance stock units.

Lemaitre Vascular Director Martha Shadan acquired 5 shares of common stock through the release of dividend equivalent rights.

A Lemaitre Vascular Senior VP reported routine acquisitions of common stock and dividend equivalent rights, alongside a tax-related sale of shares.

Lemaitre Vascular President and Director David B. Roberts reported routine transactions involving common stock and dividend equivalent rights.

LeMaitre Vascular's CFO, Dorian LeBlanc, acquired 2.8691 dividend equivalent rights, accruing on a restricted stock unit award.

Lemaitre Vascular Director Joseph P. Pellegrino JR acquired 3 shares of common stock through the release of dividend equivalent rights.

Lemaitre Vascular Director John James O'Connor reported a gift of 3,000 common shares and the acquisition of one share linked to dividend equivalent rights.

LeMaitre Vascular Director Lawrence J. Jasinski acquired one share of common stock through the release of dividend equivalent rights, increasing his direct beneficial ownership to 4,774 shares.

LeMaitre Vascular Director John Roush reported the acquisition of one common stock share and accrual of dividend equivalent rights through vesting awards.

LeMaitre Vascular Director Bridget A. Ross acquired 1 share of common stock through the vesting and release of dividend equivalent rights.

LeMaitre Vascular Director Martha Shadan reported the acquisition of common stock and dividend equivalent rights through vesting of equity awards.

LeMaitre Vascular CEO George W. LeMaitre disclosed routine stock acquisitions and dispositions related to equity awards and tax obligations.

LeMaitre Vascular's Senior VP of Operations, Trent G. Kamke, reported the acquisition of 10 common shares from dividend equivalent rights and the disposition of 53 shares for tax withholding related to a restricted stock unit vesting.

LeMaitre Vascular Director Joseph P. Pellegrino Jr. acquired 15 shares of common stock through the vesting of restricted stock units and dividend equivalent rights.

LeMaitre Vascular's Chairman and CEO, George W. LeMaitre, reported the acquisition of 45 shares and disposition of 455 shares of common stock on December 2, 2025, primarily related to RSU vesting and tax obligations.

LeMaitre Vascular President David B. Roberts reported the acquisition of 15 shares and disposition of 107 shares for tax obligations related to vested restricted stock units.

LeMaitre Vascular Director John O'Connor exercised options to acquire 7,500 shares of common stock, increasing his direct beneficial ownership.

LeMaitre Vascular's Chairman and CEO, George W. LeMaitre, exercised options to acquire 2,681 shares of common stock at $41.02 per share.

George W. LeMaitre, Chairman and CEO of LeMaitre Vascular Inc., gifted 21,300 shares of common stock to an irrevocable trust for his children.

Lemaitre Vascular Director Martha Shadan reported the acquisition of dividend equivalent rights tied to her unvested equity awards.

Lemaitre Vascular Director John A. Roush reported the acquisition of dividend equivalent rights tied to previously granted equity awards.

Lemaitre Vascular Director Bridget A. Ross reported the acquisition of dividend equivalent rights tied to existing equity awards on September 4, 2025.

Director John James O'Connor reported the accrual of dividend equivalent rights tied to restricted stock and performance share units in Lemaitre Vascular Inc.

Lemaitre Vascular Director Lawrence J. Jasinski reported the acquisition of dividend equivalent rights tied to restricted and performance stock units.

Lemaitre Vascular's Senior VP of Operations, Trent G. Kamke, reported the accrual of dividend equivalent rights tied to various restricted stock and performance share unit awards.

Lemaitre Vascular CFO Dorian Paul LeBlanc acquired 2.5281 dividend equivalent rights tied to a restricted stock unit award.

Lemaitre Vascular Director Joseph P. Pellegrino JR reported the routine acquisition of dividend equivalent rights tied to his existing restricted stock and performance share unit awards.

David B. Roberts, President and Director of Lemaitre Vascular Inc., reported the accrual of various dividend equivalent rights tied to existing equity awards.